Manufacturers Life Insurance Company, The Lyell Immunopharma, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 513,828 shares of LYEL stock, worth $4.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
513,828
Previous 551,851
6.89%
Holding current value
$4.59 Million
Previous $353,000
21.53%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$180 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$143 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$135 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$135 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$121 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $2.22B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...